DVA — DAVITA INC.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 927066 ·
Last close
$240.09
Market Cap
$15.41B
52W High
$244.49
52W Low
$148.00
ADV30
746,287
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,415,548,000 | 1,073,291,000 | 473,548,000 | 197,530,000 | 17,499,365,000 | 644,243,000 | 16,451,199,000 |
| Dec 2025 | 3,619,787,000 | 1,210,270,000 | 551,205,000 | 234,217,000 | 17,480,103,000 | 676,438,000 | 16,321,665,000 |
| Sep 2025 | 3,420,227,000 | 1,087,468,000 | 495,605,000 | 150,332,000 | 17,555,892,000 | 705,960,000 | 16,215,170,000 |
| Jun 2025 | 3,379,526,000 | 1,117,986,000 | 530,477,000 | 199,337,000 | 17,492,958,000 | 708,417,000 | 15,939,935,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,027,322,000
Investing CF
$-631,902,000
Financing CF
$-1,205,583,000
CapEx
$-534,624,000
Dividends Paid
—
Buybacks
$-1,647,465,000
EPS Diluted TTM
$10.78
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-179,242,000
Inventory
$141,613,000
Receivables
$3,012,788,000
ST Investments
$22,303,000
EBIT TTM
$1,991,726,000
Pretax Income TTM
$1,401,724,000
Interest Exp TTM
$590,002,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,835,087,872
EBITDA
$2,792,761,088
Free Cash Flow
$999,662,976
Enterprise Value
$29,692,768,256
Total Cash
$666,545,984
Total Debt
$13,220,841,472
Shares Out
64,185,000
Trailing EPS
$10.29
Book Value
$-11.41
ROE
81.0%
ROA
7.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,643,069,000 | 2,010,615,000 | 746,803,000 | 17,480,103,000 | 16,321,665,000 | — | 1,886,500,000 |
| Dec 2024 | 12,815,550,000 | 1,954,828,000 | 936,342,000 | 17,285,268,000 | 15,193,917,000 | — | 2,022,038,000 |
| Dec 2023 | 12,140,147,000 | 1,601,003,000 | 691,535,000 | 16,893,578,000 | 14,150,228,000 | — | 2,059,031,000 |
| Dec 2022 | 11,609,894,000 | 1,312,542,000 | 560,400,000 | 16,928,252,000 | 14,703,452,000 | — | 1,564,570,000 |
TTM Snapshot
Revenues TTM
$12,271,935,000
NetIncome TTM
$826,440,000
OpCashFlow TTM
$0
Assets (Latest)
$17,285,268,000
Forward EPS
$17.22
Max Pain — expiry 2026-08-21
max pain strike: $230.00 · spot: $240.09 · call oi: 4,779 · put oi: 1,900
Expected Move to 2026-08-21:
±$26.60
(11.08%) —
implied range
$213.49 –
$266.69
· ATM straddle on $240.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FMS | Fresenius Medical Care AG | $13.78B | $25.66 | — |
| FMCQF | Fresenius Medical Care AG | $13.38B | $49.82 | — |
| BTSG | BrightSpring Health Services, Inc. | $11.72B | $59.71 | — |
| THC | TENET HEALTHCARE CORP | $20.51B | $254.78 | — |
| GH | Guardant Health, Inc. | $21.48B | $161.99 | — |
News headlines (Yahoo Finance, 1h cache)
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?
2026-07-31 14:06 · Yahoo
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
2026-07-30 16:34 · Yahoo
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
2026-07-30 12:35 · Yahoo
DaVita (DVA) Stock Sees Fair Value Lift After Analyst Target Increases
2026-07-30 09:08 · Yahoo
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
2026-07-29 15:03 · Yahoo
How Xeltis Partnership And Kidney Care Initiatives Could Shape DaVita’s (DVA) Long-Term Care Strategy
2026-07-29 14:09 · Yahoo
DaVita (DVA): Buy, Sell, or Hold Post Q1 Earnings?
2026-07-29 06:05 · Yahoo
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
2026-07-28 22:00 · Yahoo
DaVita Community Care Report 2025 : Advancing Healthcare Access for Every Patient
2026-07-28 14:45 · Yahoo
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
2026-07-28 07:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.